Brian Wolpin
Affiliations: | Dana-Farber Cancer Institute, Boston, MA, United States |
Google:
"Brian Wolpin"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Singh H, Keller RB, Kapner KS, et al. (2023) Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Rubinson D, Wolpin BM, Warsofsky IS, et al. (2022) Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report. Journal of Gastrointestinal Oncology. 12: 3133-3140 |
| Biller LH, Wolpin BM, Goggins M. (2021) Inherited Pancreatic Cancer Syndromes and High-Risk Screening. Surgical Oncology Clinics of North America. 30: 773-786 |
| Chen H, Majumdar A, Wang L, et al. (2021) Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. Hgg Advances. 2 |
| Yuan C, Morales-Oyarvide V, Khalaf N, et al. (2021) Prediagnostic Inflammation and Pancreatic Cancer Survival. Journal of the National Cancer Institute |
| Kim J, Yuan C, Babic A, et al. (2020) Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology |
| Hamada T, Yuan C, Bao Y, et al. (2019) Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology |
| Hamada T, Yuan C, Yurgelun MB, et al. (2019) Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. British Journal of Cancer |
| Tiriac H, Belleau P, Engle DD, et al. (2018) Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery |
| Hamada T, Khalaf N, Yuan C, et al. (2018) Statin use and pancreatic cancer risk in two prospective cohort studies. Journal of Gastroenterology |